- Home
- HOUR vs CGTX Comparison
HOUR vs CGTX Comparison
Compare HOUR & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOUR | CGTX |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.3M | 158.8M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HOUR | CGTX |
|---|---|---|
| Price | $2.04 | $1.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.88 |
| AVG Volume (30 Days) | 106.3K | ★ 978.2K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $140,790,433.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $85.48 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.10 | $0.22 |
| 52 Week High | $6.90 | $3.83 |
Technical Indicators
Market Signals| Indicator | HOUR | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.38 | 54.36 |
| Support Level | $2.01 | $1.58 |
| Resistance Level | $2.24 | $1.81 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 56.25 | 82.30 |
Price Performance
Historical ComparisonAbout HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.